Pondy Oxides And Chemicals (532626) Q4 24/25 earnings summary

Executive summary

• Achieved record-high consolidated revenue, EBITDA, and PAT in FY25, with 5-year EBITDA and PAT CAGRs of 22% and 32% respectively, driven by robust operational execution and capacity expansion.

• Raised INR 175 crores via QIP to fund capex, working capital, and corporate purposes; strengthened balance sheet with reduced net debt and improved net debt-to-equity ratio.

• Announced highest-ever dividend at 70% (INR 3.5/share), maintaining a 29-year streak of consistent payouts, subject to shareholder approval.

• Strategic focus on expanding lead production and diversifying into copper, plastics, aluminum, and lithium-ion battery recycling.

• Statutory auditors issued an unmodified opinion on the consolidated financial results.

Financial highlights

• Standalone revenue from operations rose 33% YoY to INR 2,028 crore (₹20,283 Mn); Q4 revenue up 45% YoY to INR 517 crore (₹5,166 Mn).

• EBITDA increased 39% YoY to INR 108 crore (₹1,076 Mn); Q4 EBITDA up 31% YoY to INR 27 crore (₹272 Mn); EBITDA margin for FY25 at 5.3%.

• PAT grew 65% YoY to INR 65 crore (₹651 Mn); Q4 PAT up 46% YoY to INR 18 crore (₹180 Mn); EPS (diluted) at ₹23.63, up 40% YoY.

• Consolidated revenue for FY25 was ₹205,690.53 lakhs; net profit at ₹5,805.46 lakhs; total comprehensive income at ₹5,791.82 lakhs.

• Working capital days improved from 55 to 24 YoY; cash and cash equivalents at year-end were ₹3,928.07 lakhs.

Outlook and guidance

• Targeting 30%-35% revenue growth in FY26, with full impact from Q2 onwards; EBITDA margin guidance of 6% for FY26, aiming for 8% by 2030.

• Expecting 15% volume CAGR and over 20% profitability growth through 2030; ROCE targeted above 20%.

• Ongoing capacity expansion in lead, with Phase II expected in H2FY26; FY26 capex estimated at INR 75 crore.

• Plans to diversify into lithium-ion and forward integration, with capex funded by a mix of debt, equity, and internal accruals.